Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythromycin versus metoclopramide for feeding intolerance in very preterm newborns
IRCT20151228025732N37Phase 2Completed
- Sponsor
- Semnan University of Medical Sciences
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of erythromycin and metoclopramide in feeding intolerance (2 arms), sponsored by Semnan University of Medical Sciences. Primary endpoint: Feeding intolerance. Started Jul 2018; status: completed.
02
Drugs
erythromycinmetoclopramide
03
Conditions
feeding intolerance
Beyond the preview
Go deeper on IRCT20151228025732N37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151228025732N37.